Tom Glocer
About Tom Glocer
Tom Glocer Executive Chairman and Co-Founder
Tom Glocer serves as the Executive Chairman and Co-Founder of BlueVoyant, a cybersecurity company dedicated to improving the security posture of businesses worldwide. In addition to his role at BlueVoyant, he is also a Partner at Communitas Capital, a firm that invests in technology-driven companies. Glocer's current positions leverage his extensive experience and expertise in both technology and business sectors.
Tom Glocer Former CEO of Reuters and Thomson Reuters
Tom Glocer held the position of CEO at Reuters Group PLC and its successor company, Thomson Reuters Corp, for 11 years. During his tenure, he oversaw the strategic direction and growth of the company, navigating it through various industry changes. His leadership played a pivotal role in establishing Thomson Reuters as a leading global provider of news and information-based tools.
Tom Glocer Legal Career at Davis Polk & Wardwell
Before transitioning to leadership roles in the corporate sector, Tom Glocer worked as a mergers and acquisitions lawyer at Davis Polk & Wardwell. His legal career took him to New York, Paris, and Tokyo, where he handled various complex transactions. His legal background provided a foundation for his subsequent roles in business leadership and corporate governance.
Tom Glocer Education
Tom Glocer holds a Bachelor of Arts degree in Political Science and Government from Columbia University. Additionally, he earned his J.D. degree from Yale Law School. His academic background in political science and law has equipped him with a comprehensive understanding of both legal principles and governance, contributing to his effectiveness in various high-level executive roles.
Tom Glocer Board Memberships and Directorships
Tom Glocer serves as a director for several prominent organizations, including Merck & Co., where he is the Lead Director, Morgan Stanley, also as Lead Director, Publicis Groupe, K2 Integrity, and the Atlantic Council. His roles on these boards demonstrate his governance expertise and ability to contribute to the strategic oversight of major corporations. Furthermore, he is a trustee of the Cleveland Clinic and participates in alumni boards at Columbia and Yale Universities.